semaglutide
Treatment for Cluster Headache
Semaglutide, a GLP-1 receptor agonist, is being investigated for potential off-label use in Cluster Headache management, with emerging evidence suggesting it may modulate neuroinflammatory pathways and neuropeptide signaling. By activating GLP-1 receptors in the brain and potentially reducing calcitonin gene-related peptide (CGRP) levels, semaglutide may help decrease headache frequency and intensity in cluster headache patients.